I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Wednesday, April 15, 2015

Triple-Negative Breast Cancer “Switch” May Lead to Better Prognosis

Written by Ann Pietrangelo | Published on April 11, 2015

TNBC study on Triple Negative Breast Cancer originating in Stem Cells vs specialized cells and how inhibitor of differentiation 4 (ID4) gene plays a role in cells dividing in stem cells.

Click link to full story:
https://livingbeyondbc.wordpress.com/2015/03/03/tnbc-aware-giving-back-to-others-living-with-triple-negative-breast-cancer/

* I was quoted at the end of this article:
Five-year TNBC survivor Melissa Paskvan of Toledo, Ohio says the study gives her hope for those who will be diagnosed in the future. “TNBC survivors have been longing for a targeted therapy for some time now. This could be a game-changing discovery in how we treat TNBC in improving survival outcome in patients.”

Total Pageviews



"click image to link"